IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Nasdaq: IOVA · CIK 0001425205 · United States
Every official IOVANCE BIOTHERAPEUTICS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open IOVA filings
IOVANCE BIOTHERAPEUTICS, INC. documents
- IOVANCE BIOTHERAPEUTICS, INC. 10-K 2026IOVA 10-K 2026: annual report for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. 10-K 2025IOVA 10-K 2025: annual report for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. 10-K 2024IOVA 10-K 2024: annual report for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. 10-K 2023IOVA 10-K 2023: annual report for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. 10-K 2022IOVA 10-K 2022: annual report for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. 10-Q 2026IOVA 10-Q 2026: quarterly report for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. 10-Q 2025IOVA 10-Q 2025: quarterly report for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. 10-Q 2024IOVA 10-Q 2024: quarterly report for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. 10-Q 2023IOVA 10-Q 2023: quarterly report for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. 10-Q 2022IOVA 10-Q 2022: quarterly report for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. 8-K 2026IOVA 8-K 2026: current report for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. 8-K 2025IOVA 8-K 2025: current report for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. 8-K 2024IOVA 8-K 2024: current report for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. 8-K 2023IOVA 8-K 2023: current report for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. 8-K 2022IOVA 8-K 2022: current report for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. DEF 14A 2026IOVA DEF 14A 2026: proxy statement for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. DEF 14A 2025IOVA DEF 14A 2025: proxy statement for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. DEF 14A 2024IOVA DEF 14A 2024: proxy statement for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. DEF 14A 2023IOVA DEF 14A 2023: proxy statement for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. DEF 14A 2022IOVA DEF 14A 2022: proxy statement for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. Form 4 2026IOVA Form 4 2026: insider trading filing for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. Form 4 2025IOVA Form 4 2025: insider trading filing for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. Form 4 2024IOVA Form 4 2024: insider trading filing for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. Form 4 2023IOVA Form 4 2023: insider trading filing for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. Form 4 2022IOVA Form 4 2022: insider trading filing for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. S-1 2026IOVA S-1 2026: registration statement for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. S-1 2025IOVA S-1 2025: registration statement for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. S-1 2024IOVA S-1 2024: registration statement for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. S-1 2023IOVA S-1 2023: registration statement for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. S-1 2022IOVA S-1 2022: registration statement for fiscal 2022
- IOVANCE BIOTHERAPEUTICS, INC. 13F 2026IOVA 13F 2026: institutional holdings for fiscal 2026
- IOVANCE BIOTHERAPEUTICS, INC. 13F 2025IOVA 13F 2025: institutional holdings for fiscal 2025
- IOVANCE BIOTHERAPEUTICS, INC. 13F 2024IOVA 13F 2024: institutional holdings for fiscal 2024
- IOVANCE BIOTHERAPEUTICS, INC. 13F 2023IOVA 13F 2023: institutional holdings for fiscal 2023
- IOVANCE BIOTHERAPEUTICS, INC. 13F 2022IOVA 13F 2022: institutional holdings for fiscal 2022
More companies